1. Stimulatory effect of genistein and apigenin on the growth of breast cancer cells correlates with their ability to activate ER alpha

   • Hye-Sook Seo
   • David G. DeNardo
   • Powel H. Brown

   OriginalPaper 16 March 2006 Pages: 121 - 134

2. Hypoxia inducible factor-1α correlates with VEGF-C expression and lymphangiogenesis in breast cancer

   • Sebastian F. Schoppmann
   • Alexandra Fenzl
   • Peter Birner

   Preclinical study 23 March 2006 Pages: 135 - 141

3. A role for atm in E-cadherin-mediated contact inhibition in epithelial cells

   • Geneviève Vaudan Vutskits
   • Patrick Salmon
   • André-Pascal Sappino

   Preclinical study 16 March 2006 Pages: 143 - 153

4. The role of aromatase and 17-β-hydroxysteroid dehydrogenase type 1 mRNA expression in predicting the clinical outcome of human breast cancer

   • M. Salhab
   • M.J. Reed
   • K. Mokbel

   Preclinical study 16 March 2006 Pages: 155 - 162

5. LHRH-conjugated Magnetic Iron Oxide Nanoparticles for Detection of Breast Cancer Metastases

   • Carola Leuschner
   • Challa SSR Kumar
   • Josef Hormes

   Preclinical study 03 June 2006 Pages: 163 - 176

6. A measles virus vaccine strain derivative as a novel oncolytic agent against breast cancer

   • Cari J. McDonald
   • Charles Erlichman
   • Evanthia Galanis

   Preclinical investigation 27 April 2006 Pages: 177 - 184

7. Prognostic impact of Skp2 and p27 in human breast cancer

   • Frank Traub
   • Michael Mengel
   • Reinhard von Wasielewski

   Preclinical study 25 April 2006 Pages: 185 - 191

8. Telomere content correlates with stage and prognosis in breast cancer

   • Colleen A. Fordyce
   • Christopher M. Heaphy
   • Jeffrey K. Griffith

   Preclinical study 03 June 2006 Pages: 193 - 202

9. Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer – results of the ALMANAC validation phase

   • Amit Goyal
   • Robert G Newcombe
   • on behalf of the ALMANAC Trialists Group

   Clinical study 16 March 2006 Pages: 203 - 208

10. Chronological changes of clinical characteristics in 31,115 new breast cancer patients among Koreans during 1996–2004

    • Sei Hyun Ahn
    • Keun Young Yoo
    • The Korean Breast Cancer Society

    Epidemiology 16 March 2006 Pages: 209 - 214

11. Adherence to tamoxifen over the five-year course

    • Timothy L. Lash
    • Matthew P. Fox
    • Rebecca A. Silliman

    Epidemiology 16 March 2006 Pages: 215 - 220

12. Incidence and risk factors associated with bilateral breast cancer in area with early age diagnosis but low incidence of primary breast cancer: analysis of 10-year longitudinal cohort in Taiwan

    • Wen-Hung Kuo
    • Amy Ming-Fang Yen
    • King-Jen Chang

    Epidemiology 17 March 2006 Pages: 221 - 228

13. Flame-broiled food, NAT2acetylator phenotype, and breast cancer risk among women with benign breast disease

    • Lisa Gallicchio
    • Meghan A. McSorley
    • Kathy J. Helzlsouer

    Epidemiology 16 March 2006 Pages: 229 - 233

14. Catechol-O-methyltransferase haplotypes and breast cancer among women on Long Island, New York

    • Mia M. Gaudet
    • Jeannette T. Bensen
    • Marilie D. Gammon

    Epidemiology 05 April 2006 Pages: 235 - 240